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Abstract
Novel bifunctional N-acetylglutamate synthase/kinases (NAGS/K) that catalyze the first two steps of arginine biosynthesis
and are homologous to vertebrate N-acetylglutamate synthase (NAGS), an essential cofactor-producing enzyme in the urea
cycle, were identified in Maricaulis maris and several other bacteria. Arginine is an allosteric inhibitor of NAGS but not NAGK
activity. The crystal structure of M. maris NAGS/K (mmNAGS/K) at 2.7 A ˚ resolution indicates that it is a tetramer, in contrast
to the hexameric structure of Neisseria gonorrhoeae NAGS. The quaternary structure of crystalline NAGS/K from
Xanthomonas campestris (xcNAGS/K) is similar, and cross-linking experiments indicate that both mmNAGS/K and xcNAGS
are tetramers in solution. Each subunit has an amino acid kinase (AAK) domain, which is likely responsible for N-
acetylglutamate kinase (NAGK) activity and has a putative arginine binding site, and an N-acetyltransferase (NAT) domain
that contains the putative NAGS active site. These structures and sequence comparisons suggest that the linker residue 291
may determine whether arginine acts as an allosteric inhibitor or activator in homologous enzymes in microorganisms and
vertebrates. In addition, the angle of rotation between AAK and NAT domains varies among crystal forms and subunits
within the tetramer. A rotation of 26u is sufficient to close the predicted AcCoA binding site, thus reducing enzymatic
activity. Since mmNAGS/K has the highest degree of sequence homology to vertebrate NAGS of NAGS and NAGK enzymes
whose structures have been determined, the mmNAGS/K structure was used to develop a structural model of human NAGS
that is fully consistent with the functional effects of the 14 missense mutations that were identified in NAGS-deficient
patients.
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Introduction
In most microorganisms, fungi, and plants, two different enzymes
catalyze the first two steps in arginine biosynthesis, N-acetyl-L-
glutamate synthase (NAGS, EC 2.3.1.1) and N-acetyl-L-glutamate
kinase (NAGK, EC 2.7.2.8). However, in Xanthomonas campestris and
some other bacteria, these reactions are catalyzed by a single
bifunctional N-acetylglutamate synthase/kinase (NAGS/K), which
has been proposed to have evolved from the fusion of ancestral
NAGK and N-acetyltransferase [1,2]. In vertebrates, the major
physiological role of NAGS seems to be to regulate flux through the
urea cycle via activation of carbamyl phosphate synthase by N-
acetyl-L-glutamate (NAG), the product of the NAGS reaction.
Vertebrate NAGS do not have kinase activity, although they retain
an amino acid kinase (AAK)-like domain. Vertebrate NAGS have
25–35% sequence identity with bacterial NAGS/K, more than
their sequence identity with other bacterial, fungal or plant NAGS,
which, like vertebrate NAGS, have a non-functional AAK domain,
coupled to the N-acetyltransferase domain (NAT).
Many NAGS, NAGK, and NAGS/K enzymes are allosterically
regulated by L-arginine. In organisms that have a linear arginine
biosynthetic pathway such as Escherichia coli, the target of arginine
feedback inhibition is NAGS. In organisms that have a cyclic
pathway such as Pseudomonas aeruginosa, the main target of feedback
inhibition is NAGK [3]. However, in terrestrial tetrapods, arginine
is an activator of NAGS. The transition from inhibition to
activation appears to have occurred when tetrapods migrated from
sea to land and needed a robust system for eliminating ammonia
[4]. In the only NAGS crystal structure that has been determined,
that from Neisseria gonorrhoeae (ngNAGS), the arginine binding site is
located in the AAK-like domain, and arginine binding is
accompanied by substantial structural changes [5].
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28825Although the crystal structures of several NAGK enzymes have
been determined [6,7,8,9], NAGS enzymes have proven more
challenging and the only NAGS structure that has been
determined is that of Neisseria gonorrhoeae [10]. This enzyme is a
member of the classical bacterial and plant NAGS family, and has
less than 18% sequence similarity to mammalian NAGS enzymes.
We have now succeeded in solving the structures of two NAGS/K
enzymes, from Maricaulus maris (mmNAGS/K) and X. campestris
(xcNAGS/K) that have substantially higher sequence similarity to
vertebrate NAGS. In both crystals and solution, ngNAGS is
consistently hexameric, while mmNAGS/K and xcNAGS/K,
as determined herein, are tetrameric. Thus these new structures
are of interest in terms of understanding the evolution and
mechanisms of NAGK, NAGS, and NAGS/K enzymes, providing
potential insights into human NAGS, and perhaps in developing
a strategy for determining the crystal structure of the human
enzyme.
Results
Enzymatic activity
We have previously shown that xcNAGS/K has both NAGS
and NAGK activity and that its NAGS activity, but not NAGK
activity, is inhibited completely by 1 mM L-arginine [1]. As shown
in Figure 1, we demonstrate here that mmNAGS/K has both
NAGS (7.0 mmole/min/mg) and kinase activity (20.1 mmole/
min/mg) and that its NAGS activity is inhibited 14 fold by
1.0 mM L-arginine. NAGK activity is not inhibited by L-arginine
at physiological concentrations; instead, slight activation is
observed at 1 mM L-arginine. 76% of the maximal kinase activity
is retained even at 20 mM of L-arginine. These results are
consistent with those reported previously for xcNAGS/K [1],
which has 7.0 mmole/min/mg kinase activity at pH 6.0 and is
only slightly inhibited by 1 mM L-arginine. The kinase activity of
mmNAGS/K is somewhat lower than that of Thermotoga maritima
NAGK (tmNAGK) (45 mmole/min/mg), P. aeruginosa NAGK
(130 mmole/min/mg) and E. coli NAGK (ecNAGK) (64 mmole/
min/mg) [11,12], perhaps because of different assay conditions.
Arginine appears to regulate arginine biosynthesis in both X.
campestris and M. maris mainly by inhibiting their NAGS activity, as
is the case for E. coli [3]. This pattern may be characteristic of
bacteria that have a linear arginine biosynthetic pathway, and do
not have an ornithine N-acetyltransferase gene.
Cross-linking experiments
To determine the state of oligomerization of both xcNAGS/K
and mmNAGS/K in solution, cross-linking experiments were
performed with dimethyl suberimidate as the cross-linking agent.
Four major bands were seen for both enzymes with SDS-PAGE,
with molecular weights corresponding to oligomers of 1, 2, 3 and 4
subunits (Figure 2, Lane 3 and 4). Thus, xcNAGS/K and
mmNAGS/K appear to exist primarily as tetramers in solution.
mmNAGS/K structure determination
Determining the structure of a bifunctional NAGS/K initially
proved challenging. Of nine NAGS/K and NAGS/K-like genes
that we cloned (X. campestris, X. fastidiosa, M. maris, O. alexandrii, S.
maltophilia, P. bermudensis, S. cellulosum, K. koreensis and H. ochraceum),
only NAGS/K from X. campestris and M. maris produced diffracting
crystals.
As noted in Methods, crystals of mmNAGS/K were obtained in
trigonal space group P3121, hexagonal space group P6222 and
orthorhombic space group P212121. Crystals of the first two forms
diffracted poorly and were difficult to reproduce. Although the last
crystal form was also difficult to reproduce, crystals that diffracted
to ,3.0 A ˚ were obtained (Table 1). Several MAD data sets
collected from Se-Met substituted wild-type protein were not of
sufficient quality to locate the selenium positions. To increase
phasing power, three additional amino acids codons were mutated
to methionine (I106M, I294M and L367M). Crystals from this
mutant protein diffracted to 2.7 A ˚ (Table 1) and phase
Figure 1. Effect of L-arginine on the NAGS and NAGK activity of mmNAGS/K. A. NAGS specific activity (mmol/min/mg) was measured at
2.5 mM AcCoA and 10 mM L-glutamate in a buffer containing 50 mM Tris-HCl pH 8.5 and a range of L-arginine concentrations (0, 0.02, 0.05, 0.1, 0.2,
0.5, 1, 5 and 10 mM). B. NAGK specific activity (mmol/min/mg) was measured at 20 mM ATP and 100 mM NAG in a buffer containing 100 mM NaCl,
40 mM MgCl2, 400 mM hydroxylamine, 20 mM Tris-HCl pH 7.4 and a range of concentrations of L-arginine (0, 1, 2, 4, 10 and 20 mM). Reactions were
performed at 310 K for 30 min.
doi:10.1371/journal.pone.0028825.g001
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unit was found to consist of four subunits assembled as a tetramer,
and unit cell parameters are consistent with four subunits per
asymmetric units and 50% solvent content [13].
Cell parameters for the trigonal crystal form of mmNAGS/K are
a=b=95.1, c=253.0 A ˚ and b=120u, consistent with two subunits
per asymmetric unit and 42% solvent content. Even though this
crystal form diffracts to only 4.3 A ˚ resolution, the structural solution
in space group P3121 could be found by molecular replacement
using the A–X dimer of the P212121 crystal form as the search
model. Packing analysis indicates that the 2-fold symmetry axis of
the molecular tetramer is aligned with the 2-fold crystallographic
axis perpendicular to the plane of the tetramer ring.
xcNAGS/K structure determination
Crystals of xcNAGS/K diffracted anisotropically and had high
solvent content (75%) [2]. MAD data collected from these crystals
allowed the selenium sites to be identified, but did not have
sufficient resolution for reliable model building, particularly of the
NAT domain, and subsequent model refinement. However, the
low resolution electron density suggested that there is only one
subunit in the asymmetric unit, and that four subunits assemble to
form a tetramer aligned with crystallographic symmetries, so that
the xcNAGS/K tetramer has exact P222 point symmetry. The
molecular replacement solution with the mmNAGS/K subunit
structure as the search model confirmed these conclusions and
assignment to space group P6222 (Table S1).
Since the cell parameters of the hexagonal crystal form of
mmNAGS/K are similar to those of xcNAGS/K crystals, this
structure would be expected to be isomorphous to the xcNAGS/K
structure, with only one subunit in the asymmetric unit.
Structural variation within the tetramer
Within the P212121 mmNAGS/K tetramer, there are significant
differences between the subunits, indicating that they have
sufficient innate flexibility to respond to different packing
environments. The RMSD for superposition of the four subunits
is 1.5–2.0 A ˚, and subunits X and A are better defined than
subunits Y and B. The resolution of the electron density of several
loop regions in subunit Y, such as H4–H5, B9–B10 and H8–H9,
does not allow their structures to be modeled. The RMSD value
decreases to 0.8–1.2 A ˚ when only AAK domains are superim-
posed and to 0.4–0.7 A ˚ if only NAT domains are superimposed,
indicating that the AAK domain has more structural flexibility
than the NAT domain. The RMSD value decreases further to
0.2–0.5 A ˚ if only the core b-sheets are superimposed for both
NAT and AAK domains, demonstrating conservation of these
core structures. Structural variation among subunits in an
asymmetric unit has been observed in P. aeruginosa NAGK, where
the average RMSD was as high as 2.1 A ˚ when all Ca atoms in the
12 subunits in the asymmetric unit were superimposed [8].
The structural variation between equivalent subunits in the
native protein and Se-Met substituted mutant is much lower than
between subunits within a tetramer. The RMSD between
equivalent subunits is 0.4–0.5 A ˚ for subunits A, B, and X, and
0.8 A ˚ for subunit Y.
Structures of AAK and NAT domains
As shown in Figure 3A, each mmNAGS/K subunit has two
domains, the AAK domain (residues 1–290) and the NAT domain
(residues 292–441) connected by a hinge residue, Gly291.
The AAK domain has the typical AAK fold seen in other
NAGK structures, with an eight- strand twisted b-sheet core
(arranged as B3Q,B 6 Q,B 2 Q,B 1 Q,B 9 Q, B11Q, B12q,
B10q), with three a helices (H5, H3 and H10) on one side and
four a helices (H6, H7, H9 and H8) on the other, forming a
a3b8a4 sandwich structure (Figure 3A). a-helix H4 extends from
the C-edge of b strand B2. A long loop connecting H4 and H5
hangs over the C-edge of the b-sheet core and contains a putative
NAG binding residue, Arg99, equivalent to Arg66 in ecNAGK. A
small b-sheet consisting of four short b strands (arranged as B8q,
B7Q,B 4 Q,B 5 q) protrudes from the C-edge of the core and
forms part of the flat dimerization interface with H5, B3 and H6.
Structural homology searches using the DALI server [14]
indicate that the AAK domain is most similar to NAGK from T.
maritima (PDB: 2BTY, Z=28.2, RMSD=2.7 A ˚) with over 262
aligned residues and 26% sequence identity. The AAK domain
from ngNAGS is the second best match (PDB: 2BTY, Z=27.7,
RMSD=2.7 A ˚) with over 260 aligned residues and 21% sequence
identity.
The AAK domain can be divided further into three regions: N-
terminal segment (residues 1–39), N-terminal lobe (40–204) and C-
terminal lobe (205–290) (Figure 3A). The N-terminal segment has
two helices, in contrast to arginine sensitive NAGK and ngNAGS,
both of which have only one mobile N-terminal helix (Figure 3B)
[8,10], and arginine insensitive NAGK which has no N-terminal
segment [9].
The NAT domain has a characteristic GCN5-related N-
acetyltransferase (GNAT) fold with a central twisted seven-strand
b-sheet surrounded by six a helices (Figure 3A). The central b-sheet
consists of a four-strandanti-parallel sheet (N-terminal arm, residues
292–380, arranged as B13Q, B14q, B15Q, B16q) and a three-
strand anti-parallel sheet (C-terminal arm, residues 381–441,
Figure 2. Cross-linking of recombinant xcNAGS/K and
mmNAGS/K proteins with dimethyl suberimidate. mmNAGS/K
and xcNAGS/K (0.15 mg) were incubated with dimethyl suberimidate
(0.25 mg) in 50 ml solution containing 200 mM triethanolamine, pH 8.25
for three hours at 298 K. Lanes M, protein size markers; 1, xcNAGS/K
without cross-linking reagent; 2, xcNAGS/K with cross-linking reagent; 3,
mmNAGS/K without cross-linking reagent; 4, mmNAGS/K with cross-
linking reagent.
doi:10.1371/journal.pone.0028825.g002
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V-shaped structure, with adjacent b-strands (B16 and B17)
parallel. V-shaped central b-sheets are characteristic of the
GNAT family and are believed to be essential for catalysis of
the acetyl transferase reaction [15,16,17]. The best match with
the NAGK/S NAT domain found in a structural neighbor search
is the GNAT protein that catalyzes acetylation of the ribosomal
protein S18 (PDB 2cnm; Z=13.2, RMSD=2.4 A ˚) with over 123
aligned residues and 19% sequence identity [18]. GNAT proteins
have highly variable sequences, probably because bound AcCoA
interacts primarily with backbone rather than side-chain atoms,
and, as a result, the 7
th best match (PDB 3ne7; Z=12.0,
RMSD=2.4 A ˚) with over 119 aligned sequences, has only 6%
sequence identity.
Table 1. Diffraction data and refinement statistics for native protein and Se-MAD data.
Native Se-edge Se-inflection Se-remote
Data
Space group P212121 P212121 P212121 P212121
Wavelength (A ˚) 1.0000 0.97921 0.97934 0.97471
Resolution (A ˚) 40-3.1 40.0-2.67 40.0-2.8 40.0-2.66
Highest resolution shell (A ˚) 3.2-3.1 2.73-2.67 2.87-2.80 2.73-2.66
Unit-cell parameters (A ˚) a=114.6 a=113.3 a=113.5 a=113.4
b=118.2 b=117.4 b=117.6 b=117.5
c=152.3 c=149.1 c=149.4 c=149.3
Measurements 251,381 408,041 366,144 413,198
Unique reflections 36,398 (2,838) 56,638 (3,630) 50,373 (3,290) 57,212 (3,679)
Redundancy 6.9 (5.8) 7.2 (5.1) 7.3 (6.2) 7.2 (5.8)
Completeness (%) 95.5 (76.2)
a 99.8 (98.0) 99.8 (99.8) 99.8 (98.1)
Rmerg
b 0.092 (0.607) 0.092 (0.748) 0.096 (0.920) 0.072 (0.577)
,I/s(I). 21.7 (2.1) 27.3 (1.6) 26.3 (1.7) 36.8 (2.6)
Refinement
Reflections, working set 34,446 (2,248) 104,278 (8.580)
Reflections, test set 1,909 (108) 3,677 (333)
Total atoms (non-H) 13,265 13298
Protein atoms 12,159 13144
Ligands
CoA 2 1
Glutamate 2 0
Malonate 0 2
Others 0 3
Waters 6 84
R 0.189 (0.254) 0.183 (0.276)
Rfree 0.306 (0.359) 0.256 (0.325)
Rmsd bond lengths (A ˚) 0.009 0.009
Rmsd bond angles (u) 1.288 1.210
Average B factor (A ˚2)
Protein 118.3 82.1
CoA 170.0 121.9
Glutamate 93.0
Water 58.3 55.2
Ramachandran plot (%)
Favored 75.5 85.5
Allowed 22.2 12.9
Generous 1.7 1.8
Disallowed 0.6 0.1
aFigures in brackets apply to the highest-resolution shell.
bRmerg=ShSi|I(h,i)-,I(h).|/ShSiI(h,i), where I(h,i) is the intensity of the ith observation of reflection h,a n d,I(h). is the average intensity of redundant measurements of
reflection h.
doi:10.1371/journal.pone.0028825.t001
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matches, superimposition of the NAT domain from mmNAGS/K
with that of ngNAGS resulted in an RMSD of 2.5 A ˚ with 112
aligned residues and 15.2% sequence identity (Figure 3C). The V-
shaped core structure of the central b-sheet in the NAT domain is
similar in both structures [10]. However, there are significant
differences, particularly in the C-terminal arm. The loop that links
b-strands B18 and B19 is much shorter in mmNAGS/K than in
ngNAGS, which has two extra helices (H149 and H14). Instead,
the structure of mmNAGS/K has a long H15 a-helix, occupying
the position equivalent to H14 of ngNAGS and replacing its B24–
B25 linker. Since this linker contributes Arg425 and Ser427 to the
glutamate binding site of ngNAGS, mmNAGS/K must bind
glutamate with other residues.
Tetramer structure
The four subunits of the mmNAGS/K tetramer form an
elongated 35–74 A ˚ thick ring with a long axis of 140 A ˚ and a short
axis of 108 A ˚ (Figure 4A). The tetrameric structures of the other
two crystal forms (space groups: P6222 and P3121) are similar
(Figure S1A). Since the same tetramer is formed regardless of
crystal conditions and crystal packing, it would be expected to be
the predominant form in solution, and cross-linking experiments
confirm that xcNAGS/K and mmNAGS/K exist as tetramers in
solution (Figure 2).
Interface interactions between subunits are extensive and of
three types. There are two types of interactions between AAK
domains—interactions between adjacent subunits (A–B or X–Y)
within the ring, and interactions between subunits located on
Figure 3. Ribbon diagrams of the subunit structure of mmNAGS/K. A. Structural elements within the subunit are shown in different colors:
red, N-terminal segment; brown, N-terminal lobe of AAK domain; pink, C-terminal lobe of AAK domain; dark green, N-terminal arm of NAT domain;
light green, C-terminal arm of NAT domain. Gly291, the linker between the AAK and NAT domains, is shown in yellow. B. Superimposition of the AAK
domains of mmNAGS/K (brown) and ngNAGS (reddish brown). Arginine bound to ngNAGS is shown as blue sticks, and the extra N-terminal helix of
mmNAGS/K is shown in red. Note that the AAK domain of mmNAGS/K is in an open conformation (indicated by arrows) relative to ngNAGS. C.
Superimposition of NAT domains of mmNAGS/K (dark green) and ngNAGS (blue). Regions that differ significantly in the two proteins are shown in red
(mmNAGS/K) and salmon (ngNAGS), respectively. CoA bound between the N-terminal and C-terminal arms of ngNAGS is shown as pink sticks. The
bound NAG in ngNAGS is shown as yellow sticks.
doi:10.1371/journal.pone.0028825.g003
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interactions between the NAT domains of opposite subunits (A–X
or B–Y).
The first AAK-AAK interface, between adjacent subunits in the
ring, is similar to the dimerization surface of ecNAGK and other
enzymes of the AAK family [19] (Figure 4B). However, the specific
interactions are unique to mmNAGS/K, and different from those
of any dimer interface previously reported for any NAGK or any
other members of the AAK family, such as carbamate kinase,
glutamate 5-kinase and UMP kinase [19,20,21]. Here, the
interface consists of b strand B3 and two a helices, H5 and H6,
arranged as an aba sandwich. The interacting a-helices, H5 and
H6, (equivalent helices aC and aD in ecNAGK), and b-strand, B3,
are almost parallel to the equivalent elements from the adjacent
subunit. Residues from H6 interact with those from H5 of the
adjacent subunit via numerous hydrophobic and hydrogen bonds.
Since the distance between the two b-strands (B3) from adjacent
subunits is about 5.0 A ˚, their backbone atoms cannot hydrogen
Figure 4. Structure of the mmNAGS/K tetramer and interfaces between subunits shown as ribbon diagrams. A. The tetramer is shown
in two different orientations, perpendicular to the plane of the ring, and parallel to the plane of the ring. Subunit A (red), subunit B (green), subunitX
(purple -gray) and subunit Y (yellow). Bound CoA molecule is shown as a space-filling model. The two 2-fold non-crystallographic rotation axes in the
plane of the ring are indicated by arrows and the 2-fold non-crystallographic rotation axis perpendicular to the plane of the ring is indicated by a
filled oval. B. ecNAGK-like AAK-AAK domain interface between subunits A and B; a-helices, H5 and H6, and b-strands, B3 and B8, form this interface. C.
N-terminal helix interface between subunits A and X, formed by interactions between the two N-terminal a-helices and two neighboring helices, H3
and H10. D. NAT-NAT domain interface between subunits A and X. Two a-helices, H14 and H15, and one b-strand, B18, form this interface.
doi:10.1371/journal.pone.0028825.g004
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equivalent element from the adjacent AAK domain in an anti-
parallel mode to form an interface unique to mmNAGS/K
(Figure 4B). In total, approximately 20 hydrogen bonds, three
pairs of salt bridges (Arg168-Asp122, Arg110-Glu140, and
Arg136-Glu180) and numerous hydrophobic interactions are
involved in forming this interface.
This interface is flat with a buried area of 942 A ˚ 2, calculated
using PISA server [22] and a probe radius of 1.4 A ˚, significantly
less than those in tmNAGK (1381 A ˚ 2) and ecNAGK (1279 A ˚ 2).
The second interface, between the AAK domains of subunits on
opposite sides of the ring, involves interactions between parallel
helices of the N-terminal segment (Figure 4C), analogous to the
interactions of N-terminal helices of the AAK domains of ngNAGS
and ecNAGK; however, the specific interactions are different. The
calculated inaccessible surface of 968 A ˚ 2 for the A–X subunit
interface is larger than that of 555 A ˚ 2 for the B–Y subunit
interface. The smaller value for the latter interface may reflect the
distinctive conformation of the subunit Y, and/or the increased
disorder of its N-terminal helices relative to the other three
subunits, which led to fewer residues being included in the
structural model. The residues involved in this interface interac-
tion are mainly hydrophobic and include Ile12, Leu15, Leu16,
Met19 and Phe63, as well as one salt bridge between Arg20 and
Asp21 of opposing subunits and two hydrogen bonding interac-
tions, between Met19 O and Arg276 NH2, and between His18
NE2 and Ser59 OG. In contrast, in ngNAGS and arginine
sensitive NAGK structures, the N-terminal helices interlace with
adjacent AAK domains to form hexameric structures [6,7,8,10].
At the third interface, the C-terminal arms of NAT domains of
opposite subunits (A–X and B–Y) form a continuous 6-strand anti-
parallel b-sheet (Figure 4D). This extensive interface has a buried
area of 1485 A ˚ 2. The primary interactions consist of backbone
hydrogen bonding between equivalent B18 b-strands and cation-
p-p-cation stacking interactions between alternating side chains of
Phe398 and Arg406 from opposite subunits. Similar interfaces are
found in other enzymes with GNAT folds that form dimers in
solution using their C-terminal arms as an interface [15,17]. In
contrast, no NAT-NAT domain interactions were identified in the
ngNAGS structure [10].
The putative NAGK active site and arginine binding site
in the AAK domain
Superimposition of the AAK domain of the mmNAGS/K
structure with the ecNAGK (PDB 1gs5) structure [9] strongly
suggests that the substrate binding sites and catalytic mechanism of
their NAGK reactions are very similar. Active site residues K8,
D181 and K217 that interact with the phosphate groups of ATP in
ecNAGK are also found in mmNAGS/K (K44, D192 and K249,
respectively) and are located in similar positions (Figure S2A).
Active site residues Gly185 and Gly213 which are part of the ATP
binding pocket in ecNAGK, are also conserved (equivalent
residues Gly215 and Gly245 in mmNAGS/K). Other important
residues such as Gly11 and Gly44 (equivalent residues Gly47 and
Gly77 in mmNAGS/K), whose backbone nitrogen atoms
hydrogen bond to the c-phosphate group of ATP or the phosphate
group of NAG phosphate in ecNAGK, are conserved as well. Key
residues involved in binding NAG are also conserved (G64, R66
and N158 in ecNAGK, equivalent residues G97, R99 and N190 in
mmNAGS/K) (Figure S2A).
The characteristic sequence motif of the arginine binding site,
E-L-F-(T/S)-x-x-G-x-G-T, is strongly conserved across arginine
sensitive bacterial NAGK, fungal NAGK, classic bacterial NAGS,
bifunctional NAGS/K, and vertebrate NAGS [1,23] (Figure 5).
The structure of this binding site is also conserved in arginine
sensitive NAGK and ngNAGS [5,8]. The corresponding site in
mmNAGS/K consists of the cavity formed by the loop connecting
helix H10 and b strand B12 (residues 277–287) (Figure S2B). In
tmNAGK, Arabidopsis thaliana NAGK (atNAGK), and ngNAGS
structures, residues in the N-terminal helix (H1) (Tyr15 in
tmNAGK, Lys32 and Phe33 in atNAGK, Tyr17 in ngNAGS)
form part of arginine binding site [5,7,8]. In mmNAGS/K, Tyr28
and nearby residues in the second N-terminal helix, H2, are
positioned to play this role.
The mechanisms by which arginine binding strengthens
interdomain interactions in ngNAGS and mmNAGS/K may also
be similar. In ngNAGS, arginine binding enhances AAK-NAT
domain interactions by creating new hydrogen bonding interac-
tions between Arg255-Asp334, Tyr17-Asn336 and Arg274-
Gln362 [5]. The arginine binding site in mmNAGS/K is close
to the NAT domain ‘‘P-loop’’ which is likely to interact with the
pyrophosphate group of AcCoA. This creates the possibility of
bound arginine or nearby residues in the AAK domain interacting
with residues such as Glu366 in the ‘‘P loop’’, thereby regulating
the binding of AcCoA.
Since mutations in the arginine binding site of the kinase
domain of both mouse NAGS and xcNAGS/K [4] eliminate
arginine’s effect on NAGS activity, bifunctional NAGS/K would
not be expected to have two arginine binding sites, one affecting
NAGS activity and the other one affecting NAGK activity.
Although arginine has been reported to inhibit the NAGS activity
of the short version of NAGS, which consists of only the NAT
domain, from Mycobacterium tuberculosis [24], it has not yet been
shown that this NAGS domain has a specific arginine binding site.
Non-productive and putative CoA binding sites
Although both native and mutant mmNAGS/K were incubated
with 25 mM CoA before crystallization, only one bound CoA
molecule per tetramer, with incomplete occupancy, was identified
in the cleft between the NAT domains of subunits B and Y in the
mutant structure (Figure 6A). In the native structure, this CoA
molecule was visible, as well as a second molecule in the cleft
between subunits A and X (Figure S1B). This CoA binding site
does not correspond to the CoA binding site in ngNAGS [10] and
other GNAT enzymes [17,25] and is unlikely to be functional,
since most of the residues forming the binding site are not
conserved and there is no glutamate binding site close by. The sub-
optimal pH and high ionic strength of the crystallization
conditions may be a factor in CoA binding to a non-functional
site rather than the native active site. Substrate binding at a non-
functional site rather than the active site has been observed in
many other enzymes [26,27].
Although sequence similarity among GCN5-fold acetyltransfer-
ases is low (6–12% sequence identity), the AcCoA binding site is
conserved across all enzymes that have been studied [25,28].
Therefore, the protein residues that interact with AcCoA in
mmNAGS/K can be predicted by superimposing other known
acetyltransferase structures [5,10,18] (Figure 3C and Figure S2C).
The ‘‘P-loop’’ (Arg364-Gly365-Glu366-Gly367-Leu368-Gly369) is
consistent with the consensus sequences [Q/R]-x-x-G-x-[G/A]
[29] characteristic of AcCoA binding sites and is located close to
the pyrophosphate moiety. The S-acetylpantetheine moiety of
AcCoA probably forms a pseudo-antiparallel b-sheet interaction
with B16, positioning the acetyl group in almost the same plane as
the b-sheet. Tyr397 and Ser387 are within hydrogen bonding
distance of the sulfhydryl group of AcCoA and could act as the
active site acid and base, respectively. A highly conserved tyrosine,
which is equivalent to Tyr397 in mmNAS/K, has been identified
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considered to be catalytically important [28].
Glutamate binding site
Although the sequence similarity between mmNAGS/K and
ngNAGS is too low to locate the glutamate binding site, structure
alignment enables the probable site to be identified. In all known
acetyltransferase structures, the substrate that accepts the acetyl
group from AcCoA approaches from the opposite side of the b-
sheet (the same side as a-helix H15) for in-line nucleophilic attack
on the Re face of the acetyl group of AcCoA. Therefore, the
glutamate site in mmNAGS/K is likely to correspond to this site in
ngNAGS (PDB 3d2m) [10]. In the native mmNAGS/K structure,
there is residual electron density in subunits A and Y at this site
Figure 5. Sequence alignment of mmNAGS/K, xcNAGS/K, zebra fish NAGS and human NAGS. The sequence encoding secondary
structure elements are indicated by boxes in yellow-green (b-strand) and red (a-helix). Encoded amino acids that are modeled in binding of ligands
(ATP, NAG, AcCoA, glutamate, L-arginine), are indicated in blue. The linker residue, Gly291, is boxed. The missense human mutations are indicated by
boxes in red, yellow-green, light blue for neonatal, late-onset and unknown onset patients, respectively.
doi:10.1371/journal.pone.0028825.g005
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this site is likely to be the biologically relevant L-glutamate binding
site. The equivalent site in the Se-Met substituted mutant structure
has residual electron density that can be modeled as malonate
which was present at a high concentration in the crystallization
buffer.
The c-carboxyl group of L-glutamate appears likely to be
anchored by Arg386, Lys356 and Thr436 (Figure 6B), while the a-
carboxyl group may be fixed by hydrogen bonding interactions
with the main chain N atom of Phe357 and the main chain O
atom of Arg386. The side chains of hydrophobic residues Phe316,
Leu437 and Trp410 are also part of the L-glutamate binding site.
The residues involved in binding L-glutamate are highly
conserved. Lys356 and Phe357 are part of the conserved motif
Tyr353-Leu354-Asp355-Lys356-Phe357 (YLDKF), and Arg386 is
part of the conserved motif Trp385-Arg386-Ser387-Arg388
(WRSR). These conserved motifs are found in all bifunctional
NAGS/K, as well as vertebrate and fungal NAGS, implying a
common binding mechanism (Figure 5). Similarly, Tyr397, Ser387
and Asn391, which have roles in the catalytic reaction, are also
highly conserved, implying a common catalytic mechanism.
Protein flexibility encoded intrinsically in the structure
The variability in the structures of the four subunits in the
asymmetric unit of the P212121 crystal and in crystals obtained
under different conditions and in different space groups provides
an opportunity to study the conformational range of NAGS/K
and its relationship to the catalytic and regulatory mechanisms.
When the b-sheet cores of the AAK domain of the Se-Met
substituted mutant are superimposed, it is immediately apparent
that the NAT domain can adopt different orientations relative to
the AAK domain (Figure S3A). Relative to subunit Y, the NAT
domains of subunits B, X, and A are rotated 25.2u, 24.7u, and
16.9u toward the AAK domains, respectively. To test whether the
difference in relative domain orientation in subunits Y and B
might be related to L-arginine binding, CoA and L-arginine were
modeled in their proposed binding sites. The clefts between the
AAK and NAT domains of subunits B and X are in a closed
conformation, creating a steric clash between bound CoA and the
arginine binding loop (residues 281–287) (Figure S3B). This clash
does not exist in subunit Y (Figure S3C). The closed conformation
of subunits B and X may represent the conformation that exists
when L-arginine is bound, while the open conformation of subunit
Y and probably subunit A may represent the active form without
L-arginine bound. Interestingly, in native mmNAGS/K, gluta-
mate can only be identified in subunit Y and A (Figure S1B).
There may also differences in the inter-lobe movements of the
AAK domains of different mmNAGS/K subunits and between
mmNAGS/K and xcNAGS/K. AAK inter-lobe movement has
been demonstrated in ecNAGK [30]; upon ATP binding the C-
terminal lobe rotates 24u–28u towards the N-terminal lobe, where
the NAG binding site is located. The conformations of the AAK
domain in our structures are all in the open conformation, which is
consistent with structures without ATP or ADP bound.
In addition to the large inter-domain rotation between the AAK
and NAT domain, and inter-lobe movement within the AAK
domain, several loops in the AAK domain may exhibit large
movements. Specifically, the NAG binding loop (residues 89–104),
which contains a NAG binding residue, Arg99 (Figure S2A),
would be expected to move more than 5.0 A ˚ when NAG binds. In
Figure 6. CoA and glutamate binding sites of mmNAGS/K. Bound CoA and glutamate molecules are shown as pink sticks. Omit electron
density maps (Fo-Fc) around bound CoA (contoured at 2.0 s) and glutamate (contoured at 3.0 s) are shown as blue cages. The side chains of
surrounding residues are shown as pink sticks. A. The non-functional CoA binding site in the cleft formed by adjacent NAT domains. Residues Arg406,
Arg407, Glu408, Asp425 and Glu428 from subunit B, and Asp402, Trp414, Glu417 from subunit Y form this CoA binding cleft. The sulfur atom of CoA
is fully exposed to the solvent. B. Glutamate binding site in the native mmNAGS/K structure, remote from the non-functional CoA binding site.
doi:10.1371/journal.pone.0028825.g006
Structure of N-Acetylglutamate Synthase/Kinase
PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28825the mmNAGS/K structure, the NAG binding loop is very flexible,
reflected by a weak electron density.
In contrast to the AAK domain, the NAT domain appears to be
less flexible with the inter-arm rotation among different subunits
varying by only 2–3u. However, the ‘‘P-loop’’ (residues 360–370),
which is likely to be involved in binding of the pyrophosphate
group of AcCoA, probably moves ,1.0 A ˚ when the substrate
binds.
Human NAGS model
Since the primary sequences of mmNAGS/K and human
NAGS have ,31% identity while the sequence identity of
ngNAGS and human NAGS is only 17%, mmNAGS/K is likely
to be a more reliable structural model for human NAGS than
ngNAGS [5,10]. The human NAGS structure built with
mmNAGS/K as the model using Swiss-model web server
[31,32,33] is shown in Figure 7, with naturally occurring missense
mutations identified in patients with clinical hyperammonemia
shown as spheres. Among 14 missense mutations, 6 are located in
the AAK domain and 8 are located in the NAT domain. The four
neonatal missense mutations (S410P, L430P, W484R and A518T)
are all located in the NAT domain close to the putative substrate
binding sites. The model predicts that the side chain of Cys200 will
be close to the side chain of Cys259 and could be potentially form
a disulfide bond as previously predicted [34]. It also predicts that
the arginine binding site and AcCoA binding site will be close to
each other, and that the orientation of the NAT domain relative to
AAK domain will be intermediate between those of subunits Y
and B in the mmNAGS/K structure. The model predicts that
arginine binding will not cause closure of the AcCoA binding site
because of the steric restraints imposed by the non-glycine hinge
residue (Ala375). This prediction is consistent with arginine’s role
as an allosteric activator of human NAGS.
Discussion
Although the subunit structures of bifunctional NAGS/K and
classical bacterial NAGS have some similarities, there are
substantial differences between them. Both have two-domain
structures, consisting of a typical AAK fold and a GCN5-related
NAT fold. The AAK domains are very similar, except for an extra
N-terminal helix (Figure 3B) in mmNAGS/K. However, there are
significant differences in the structures of the NAT domain,
particularly in the C-terminal arm (Figure 3C). Importantly, the
linker between the two domains consists of one amino acid in
mmNAGS/K vs. three amino acids in ngNAGS, allowing much
stronger interdomain interactions in mmNAGS/K than in
ngNAGS, and different relative domain orientations (Figure
S4A–B). As a result, the putative arginine and AcCoA binding
sites are in proximity only in mmNAGS/K, creating the possibility
of allosteric interactions between the binding sites.
However, the largest difference between mmNAGS/K and
ngNAGS involves the quaternary structure. While the mmNAGS/
K holoenzyme is organized as a tetrameric ring, ngNAGS
functions as a hexamer (Figure S4C–D) [10]. The tetramer of
mmNAGS is formed by AAK-AAK and NAT-NAT domain
interactions which are unique to mmNAGS/K, while the hexamer
of ngNAGS is stabilized by interactions between AAK domains at
two major interfaces (the ecNAGK-like interface and the arginine-
sensitive NAGK-like N-terminal interlaced helix interface) without
Figure 7. Structural model of human NAGS shown in stereo view as a Ca-trace. Modeled bound arginine, CoA and NAG are shown in stick
mode. The C
a atoms of residues with missense mutations identified in NAGS deficient patients are shown as red (neonatal onset – severe phenotype)
or green (late onset – mild phenotype) or blue (unknown onset) spheres.
doi:10.1371/journal.pone.0028825.g007
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that do not have a NAT domain have similar hexameric ring
structures [8] confirming that a NAT domain is not important in
the hexameric quaternary structure.
The mechanism of NAGS activity regulation by arginine
appears also to be different in the two enzyme groups. In
ngNAGS, the conformational changes induced by arginine
propagate from the AAK domain to the NAT domain via the
interdomain linker, re-orienting the NAT domain, and as a
consequence disordering the glutamate binding loops to reduce
enzyme activity [5]. In contrast, in mmNAGS/K, the interdomain
interaction is stronger and the marked relative domain rotation
proposed to occur upon L-arginine binding would close the AcCoA
binding cleft preventing AcCoA from binding. The proposed
regulatory mechanism of arginine is shown in Figure 8A. These
differing allosteric mechanisms for arginine in the two enzyme
Figure 8. Proposed mechanism of arginine regulation of mmNAGS/K. A. The active form of mmNAGS/K with bound AcCoA (shown as a stick
model) is based on the structure of subunit Y. Arginine (shown as a stick model) bound to the inactive form is based on the structure of subunit B.
The NAT domain (green ribbons) rotates ,26u relative to the AAK domain (shown as red ribbons) when arginine binds, thus preventing AcCoA from
binding. The linker, Gly291, is shown in yellow. B. Sequence alignment of the arginine binding and AAK-NAT linker regions, with arginine binding
amino acids in blue and linker amino acids in red.
doi:10.1371/journal.pone.0028825.g008
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experiments. While arginine decreases ngNAGS activity by
decreasing glutamate binding affinity [5], in xcNAGS/K and
mmNAGS/K, arginine binding probably prevents binding of
AcCoA [1,4].
As discussed above, and consistent with the above mechanisms,
the length of the inter-domain linker appears to play a key role in
the strength of the interactions between the AAK and NAT
domains and the proximity of the arginine and CoA binding sites
to each other. In addition, sequence comparisons indicate a clear
correlation between the sequence of the linker and the allosteric
effect of arginine (Figure 8B). In all bifunctional NAGS/K and fish
NAGS (fugu fish, zebra fish and tetraodon) in which arginine
inhibits NAGS activity, the linker consists of a glycine. When the
effect of arginine is neutral, as in frogs, or activating, as in
mammals, the linker contains an alanine, cysteine, or threonine,
but never glycine. It appears that the steric constraints imposed by
a non-glycine residue limit the magnitude of the conformational
changes that can be induced by arginine and give rise to the
variable allosteric effect of arginine on NAGS activity. Partial
inhibition of NAGS activity by arginine in fish is further influenced
by neighboring amino acid residues [4]. Even though the
differences in the linker appears to play major role in the variable
arginine effect on NAGS activity, other residues such as Arg276,
His281, Glu366 which are located in NAT and AAK interface
may also be involved.
Twenty one deleterious mutations that cause human disease
(hyperammonemia) have been reported to date [34]. Among them
14 are missense substitutions that may have structural relevance.
Since patients with NAGS deficiency can be rescued by the
administration of the NAG analogue, N-carbamylglutamate,
identifying deleterious mutations that are likely to produce
hyperammonemia is useful clinically [35,36]. It is therefore
important to be able to predict the functional effects of amino
acid substitutions on structure and function of the enzyme. In this
regard a reliable protein structure of mammalian NAGS would be
very useful. Unfortunately, mammalian NAGS has proven
recalcitrant to crystallization and the current mmNAGS/K
structure provides the most reliable model to date for human
NAGS. This model allows the potential impact of NAGS
mutations on structure and function to be examined.
Known naturally occurring amino acid substitutions predicted
from mutations in the NAGS gene have been mapped onto a
human NAGS model (Figure 7) based on the mmNAGS/K
structure [34]. Since the active site is located within the NAT
domain, while the AAK domain has only structural and regulatory
roles, with arginine enhancing NAGS activity in human NAGS,
mutations in the NAT domain might be expected to have more
severe functional and clinical consequences, presenting clinically at
birth or shortly thereafter, while mutations in the AAK domain
might be expected to allow residual enzymatic activity and to have
milder phenotypes. Indeed, 5 of the 6 mutations in the AAK
domain are associated with a milder (late onset) phenotype, while
the age of onset of the patient with the sixth mutation (G236C) is
unknown. In contrast, 4 of the 8 missense mutations in the NAT
domain are associated with a severe (neonatal onset) phenotype.
Materials and Methods
Cloning and protein expression and purification
The argA/B gene was PCR amplified from M. maris MCS10
genomic DNA (generously donated by Dr. Craig Stephens,
Biology Department, Santa Clara University, 500 El Camino
Real, Santa Clara, CA) using Phusion
TM polymerase (Finnzymes,
New England BioLabs) and the primers 59-CATATGAATCC-
GAATGCACCGGG-39 and 59-GGATCCTCATTGCGGCG-
CCTCAAGGGT-39. The PCR product was cloned into a TOPO
vector using a Zero-Blunt TOPO cloning kit (Invitrogen). NdeI and
XhoI (New England BioLabs) were used to transfer the argA/B gene
from TOPO to the expression vector pET28a (Novagen) using T4
DNA ligase (Invitrogen) which was then transformed into Rosetta
2 cells (Novagen) for expression. An ABI PRISM 3130 Genetic
Analyzer (Applied Biosystems) was used to confirm the sequence
by DNA sequencing. Protein overexpression was induced by
incubating overnight with 0.2 mM IPTG at room temperature
(,298 K). The expressed protein has 20 non-native amino acid
residues (MGSSHHHHHHSSGLVPRGSH) at its N-terminal
including six His residues and a thrombin recognition site
(underlined). The cells were harvested by centrifugation, suspend-
ed in 30 ml of Ni-affinity lysis buffer (20 mM NaH2PO4, 300 mM
NaCl, 10% (v/v) glycerol, 10 mM b-mercaptoethanol, pH 7.4)
and disrupted by sonication. The protein was then purified using
an A ¨KTA FPLC system (GE Healthcare) following the protocol
described previously [2]. Protein concentrations were determined
by the Bradford method using the BioRad protein-assay dye
reagent with bovine serum albumin as a standard [37].
The Se-Met substituted NAGS/K protein was prepared using
the Overnight Express Auto-induction System 2 (Novagen) as
described previously [2]. In brief, the expression plasmid was
transformed into a metE minus host strain B834(DE3) (Novagen).
The clone was inoculated into 1L sterile deionized water
supplemented with the chemicals provided in the kit, 125 mg L-
selenomethionine and 50 mg kanamycin. Vitamin B12 (cyanoco-
balamin) was added to a final concentration of 100 nM and the
culture was incubated at 303 K for 16 hours. After reaching
stationary phase, the cells were harvested and the protein was
purified as described above for the native protein.
The Se-Met substituted protein was characterized using a 4700
ABI TOF/TOF mass spectrometer (Applied Biosystem) operated
in reflection positive ion mode as described previously [38].
Approximately 10 mg of purified native or Se-Met substituted
protein were digested overnight at 310 K using Promega
sequencing grade trypsin (enzyme/protein ratio, 1:50, w/w) in
50 mM ammonium bicarbonate (pH 7.4). After desalting, 0.3 mL
of the resulting peptide solution was mixed with 0.3 mLo f
saturated a-hydroxycinnamic acid and spotted on the MALDI
plate. The Se-Met substituted peptides were identified using the
characteristic features of the isotopic distribution of selenium. The
intensity was compared to the native peptide signal at a position of
257 Da to establish that more than 80% of the protein was Se-
Met substituted.
Site-directed mutagenesis
Site-directed mutant genes of M. maris NAGS were created by
utilizing primers containing the desired mutations (Table 2) and
Quik Change Mutagenesis Kit according to the manufacturer’s
protocol (Strategene). Initially, a thermal cycle was applied to
Table 2. Mutagenesis primers.
Mutants Primers
I106M ACCCGCGACGAGGCGATGCCGATCATCCGGGATAC
I294M CAGGGGCGAGCGGATGGTCGCCACCGATGAC
L376M ACGGTGTGGAACCGGATGGTCGATTATTGCAC
doi:10.1371/journal.pone.0028825.t002
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and then the appropriate mutagenic primer was annealed to it.
PfuTurbo DNA polymerase from the Quik Change kit was used to
extend the primer without primer displacement and to seal nicks.
The product was treated with DpnI to digest parental plasmids,
which are susceptible because of their methylated DNA. Then,
transformation into XL10-Gold ultracompetent cells allowed
conversion of mutated single stranded DNA to double stranded
plasmid DNA. Finally, the sequences of mutant DNA sequences
were verified by an ABI PRISM 3130 Genetic Analyzer (Applied
Biosystems) using the commercially available primer pair annealed
to the plasmid promoter and terminator regions.
To increase the number of methionine residues available for
experimental phasing, Ile106, Ile294 and L376 were mutated to
Met simultaneously, using the sequences of homologue protein
from other bacteria as a guide. The mutant was overexpressed and
purified in the same way as wild-type protein.
Biochemical characterization: Activity assays and
cross-linking experiments
The NAGS and NAGK activities of mmNAGS/K were
measured in the presence of different concentrations of L-arginine
using the method described previously [1]. In NAGS assays,
0.16 mg of enzyme were incubated in 100 ml of assay solution
containing 2.5 mM AcCoA, 10 mM L-glutamate and 50 mM
Tris-HCl pH 8.5 at 293 K for 5 min. The reaction was stopped
with 100 ml of 30% TCA. NAG was quantified using liquid
chromatography-mass spectrometry. The arginine titration curve
was obtained using different concentration of L-arginine. For
NAGK activity, the enzyme (0.2 mg) was incubated in the 500 ml
assay buffer containing 20 mM ATP, 100 mM NAG, 100 mM
NaCl, 40 mM MgCl2, 400 mM hydroxylamine and 20 mM Tris-
HCl pH 7.4 for 30 min at 310 K. The reaction was terminated by
adding 450 ml ferric chloride solution (5% FeCl3, 5% TCA and
0.3 M HCl). The absorption for the colored reaction mixture was
measured at 540 nm. Cross-linking experiments were performed
using the protocol described by Davies and Stark [39].
mmNAGS/K and xcNAGS/K (0.15 mg) were incubated with
cross-linking reagent dimethyl suberimidate (0.25 mg) in 50 ml
solution containing 200 mM triethanolamine, pH 8.25 three
hours at 298 K. Samples with and without cross-linking reagent
were subjected to sodium dodecyl sulfate polyacrylamide get
electrophoresis (NuPAGE 4–12% Bis-Tris gel) in MES SDS buffer
(50 mM MES, 50 mM Tris base, 0.1% SDS, 1 mM EDTA,
pH 7.3) and stained with Coomassie blue. Benchmark with
premixed different molecular weights of protein standards was
purchased from Invitrogen.
Crystallization
The purified protein was concentrated to 16 mg/ml with an
Amicon-Y30 membrane concentrator (Millipore). Screening for
crystallization conditions was performed using sitting-drop vapor
diffusion in 96-well plates (Hampton Research) at 291 K by mixing
2 ml oftheproteinsolution with 2 ml ofthe reagent solutionfrom the
sparse matrix Crystal Screens 1 and 2, and Index screen (Hampton
Research). Further optimizations of the crystallization conditions
were carried out using the hanging-drop vapor diffusion method.
Before crystallization, the enzyme was incubated with 25 mM
CoA and 100 mM glutamate at 277 K for 1 hour. Different
crystallization conditions yielded several different crystal forms:
orthorhombic (space group P212121), trigonal (space group P3121)
and hexagonal (space group P6222). The best orthorhombic form
crystals for native and NAGS were grown from a well solution
containing 25% PEG3350, 200 mM NaCl and 100 mM Bis-Tris,
pH 6.5. The best crystallization conditions for the Se-Met
substituted mutant were 25% PEG3350, 200 mM sodium
malonate, pH 7.0. The trigonal form crystals were obtained from
a well solution containing 23% PEG400, 100 mM Bis-Tris pH 6.5
and 1 mM 5-amino-2,4,6-triiodoisophthalic acid. Hexagonal
form crystals were produced from a solution containing 25%
PEG3350, 100 mM Li2SO4 and 100 mM Tris pH 9.0 and have
the same morphology as the hexagonal bipyramid crystals of
xcNAGS/K [2].
Data collection and structure determination
Before data collection, crystals were transferred from the cover
slip on which they were grown to a well solution supplemented
with 25% ethylene glycol and then frozen by direct immersion into
liquid nitrogen. Data sets for Se-Met substituted proteins were
collected at the selenium adsorption edge, the inflection point and
a remote position at the SER-CAT advanced Photon Source.
Data sets for the native crystals were collected to ,3.1 A ˚
resolution for the orthohombic crystal form and ,4.3 A ˚ resolution
for the trigonal crystal form, respectively. All data were processed
using the HKL2000 package [40]; statistics are summarized in
Table 1. The diffraction data for the hexagonal crystal form of
xcNAGS/K were reported previously [2].
The mmNAGS structure was solved using the three wavelength
MAD (3W-MAD) protocol of Auto-Rickshaw: the EMBL-
Hamburg automated crystal structure determination platform
[41]. The input diffraction data were prepared and converted for
use in Auto-Rickshaw using programs in the CCP4 suite [42]. The
structure-factor amplitudes of anomalous scatterers (FA values)
were calculated with the program SHELXC [43]. Based on an
initial analysis of the data, the maximum resolution for
substructure determination and initial phase calculation was set
to 3.2 A ˚. The 25 Se atoms were identified using the program
SHELXD [44] and the correct hand for the substructure was
determined using the programs ABS [45] and SHELXE [43].
Occupancies of all substructure atoms were refined and initial
phases were calculated with MLPHARE [42]. Density modifica-
tion, phase extension and NCS-averaging were performed with
RESOLVE [46]. A partial a-helical model contained 1503
residues out of a total of 1764 was produced with HELICAP
[47]. After model adjustments with Coot [48], structural
refinements were performed with Phenix [49]. During the initial
stages of the refinement, NCS restraints were used and R and Rfree
dropped to 32.0 and 42.6%, respectively, but did not decline
further. In subsequent refinements, NCS restraints were removed
and the structural models for each subunit were adjusted
individually, revealing significant conformational differences
between subunits. The final refinement without NCS restraints,
but with translation/libration/screw parameters [50] included
resulted in R and Rfree values of 18.9% and 25.6%, respectively.
The rather large difference between R and Rfree is probably due to
anistropic diffraction. The translation/libration/screw groups
were selected based on five structural regions per subunit as
shown in Figure 1A. The final model contains 4 protein subunits, 1
CoA, 2 malonates, 2 ethylene glycols, 1 sulfate group and 84 water
molecules. The native structure was refined and modeled in the
same way as the Se-Met substituted protein, but with a new set of
random reflections chosen for the calculation of Rfree. The final
native structure model has 4 protein subunits, 2 CoAs, 2
glutamates and 6 water molecules. Refinement statistics for the
final refined model are given in Table 1.
The structure of the trigonal crystal form was solved in space
group P3121 with the dimer of subunits A and X of the
orthorhombic crystal form as the search model and the program
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to 42.9% and 43.1%, respectively, confirming the correctness of
the structural solution. Further refinement with the reference
model (Se-Met substituted mmNAGS/K structure) restraints
resulted in R and Rfree values of 27.4% and 41.9%, respectively
(Table S1). The structural refinement greatly improved when
additional restraints from known homologous structures were
introduced [53].
The structure of the hexagonal form of xcNAGS/K was solved in
space group P6222 using CaspR, the web-server for automatic
molecular replacement [54] and the structure of mmNAGS/K as
the search model. The solution from molecular replacement is
consistent with the electron density map constructed using
experimental phases from MAD data [2]. Rigid body refinement
reduced R and Rfree values to 49.6% and 48.7%, respectively. After
mutatingresiduesfromthemmNAGS/KsequencetothexcNAGS/
K sequence and manual model rebuilding, further refinement
brought R and Rfree values down to 31.9% and 38.4%, respectively.
Since the dataset was collected at the selenium edge from Se-Met
substituted crystals and contained anomalous signals, scattering
factors were included in the refinement. The refinement improved
significantly for low resolution data with the inclusion of anomalous
diffraction data, as reported [55]. Data collection and final
refinement statistics for the trigonal crystal form of mmNAGS/K
and hexagonal form of xcNAGS/K are listed in Table S1.
Structural modeling
The structural model for human NAGS subunit was built using
the Swiss-Model web server and the mmNAGS/K structure
(subunit A) as the template [31,32,33]. The model, checked using
program PROCHECK [56], has good stereo geometry with
86.2% dihedral angles in the most favored region of the
Ramachandran plot and 11.9% in the generally allowed region.
There are 9 bad contacts in the model. Coordinates for human
NAGS model are provided in Supporting Information S1
(hNAGS-model.pdb).
Figures were drawn using programs Alscript [57], Pymol [58]
and VMD [59]. The secondary structure was assigned using
STRIDE web server [60].
Protein Data Bank accession numbers
The final refined coordinates of the native and Se-Met
substituted mutant structures of mmNAGS/K in orthorhombic
space group P212121 and in trigonal space group P3121, and the
Se-Met substituted structure of xcNAGS/K in hexagonal space
group P6222 have been deposited in RCSB Protein Data Bank
with accession codes, 3S6H, 3S6G, 3S7Y and 3S6K, respectively.
Supporting Information
Figure S1 A. Molecular packing of mmNAGS in the unit cell in
space groups P212121 and P3121, and of xcNAGS/K in space
group P6222. Different tetramers are shown in different colors. B.
Ribbon diagram of native mmNAGS/K tetramer structure with
subunit A (red), subunit B (green), subunit X (purple -gray) and
subunit Y (yellow). Two bound CoA and glutamate molecules are
shown as space-filling models. Glutamate binding site is remote
from the non-functional CoA binding site.
(TIF)
Figure S2 A. Stereo diagram of the superimposition of the AAK
domain of mmNAGS/K (shown as red ribbon) and ecNAGK
(shown as pink ribbon) (PDB 1GS5). AMPPNP (ATP analog) and
NAG are shown as light-blue sticks. The side chains of key catalytic
residues are shown as yellow sticks. B. Stereo diagram of
superimposition of AAK domain of mmNAGS/K (red ribbon)
and arginine bound ngNAGS (pink ribbon, PDB 3D2P) showing the
proposedargininebindingsite.Arginine(showninlight-bluesticks)is
located in the cavity formed by the loop connecting helix H10 and b
strandB12.Sidechainsofkeysiteresiduesareshowninyellowsticks.
C. Stereo diagram of superimposition of the NAT domain of
mmNAGS/K (red ribbon) and ngNAGS (pink ribbon, PDB 3B8G)
showing the proposed CoA (yellow sticks) binding site in the V-
shaped cleft formed by the N-a n dC-terminal arms of NAT domain.
Side chains of key site residues are shown as light-blue sticks.
(TIF)
Figure S3 A. Relative rotation of the AAK and NAT domains of
the four subunits of unliganded mmNAGS/K. Stereo view of the
Ca-trace representation of the four subunits of the asymmetric unit
with the core b-sheets of the AAK domains superimposed. Red,
subunit A; green, subunit B; purple-grey, subunit X; yellow, subunit
Y. B. Ribbon diagram of subunit B with modeled CoA, NAG and
arginine bound. The circle indicates the proposed steric clash
between CoA and the arginine-binding loop in the conformation of
subunit B. CoA, NAG and arginine are shown in sticks. C. Ribbon
diagram of subunit Y with modeled CoA, NAG and arginine
bound. The coordinates of CoA and NAG were obtained by
structurally superimposing the NAT domain of ngNAGS (PDB
3B8G) and that of subunit B or subunit Y of mmNAGS/K.
(TIF)
Figure S4 Comparison of mmNAGS/K and ngNAGS. A. Stereo
diagramofsuperimpositionofmmNAGS/K(subunitA,redribbon)
and arginine bound ngNAGS (pink ribbon, PDB 3D2P) with the
core b-sheets of the AAK domains superimposed. Bound CoA and
arginine are shown in space-filling mode. B. Stereo diagram of
superimposition of mmNAGS/K (subunit A, red ribbon) and CoA
and NAG bound ngNAGS (pink ribbon, PDB 3B8G) with the core
b-sheets of the AAK domains superimposed. Bound CoA (light-
blue) and NAG (green) are shown in space-filling mode. C.
Simplified structural model of the mmNAGS/K tetramer. D.
Simplified structural model of the ngNAGS hexamer (PDB 3B8G).
Different subunits are shown in different colors.
(TIF)
Table S1 Diffraction data and refinement statistics for
mmNAGS/K and xcNAGS/K in space groups P3121 and P6222.
(DOC)
Supporting Information S1
(PDB)
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